title: Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy.
abstract: We describe a 65-year-old woman who had had wart-like lesions on the hands, lower arms and forehead for about 45 years. She had already had several basal cell carcinomas excised. Histological study, electron microscopy and in situ hybridization [human papilloma virus (HPV)-types 5/8/12/14/19-23/25/36] of skin biopsies confirmed a diagnosis of epidermodysplasia verruciformis (EV). Photodynamic therapy (PDT) was performed using a 20% 5-aminolaevulinic acid ointment applied for 6 h to the lesions and irradiating using an incoherent light source (lambda = 580-740 nm, 160 mW/cm2, 160 J/cm2). Following PDT, blistering and crusting of the lesions occurred, but these healed completely within 2-3 weeks without scarring, and the cosmetic result was excellent. Six months after PDT a skin biopsy was taken. In situ hybridization was positive for HPV type 8 in skin which was clinically and histologically normal. Twelve months after PDT a few lesions had recurred on the hands. Although permanent cure of EV cannot be achieved by any therapy at present and single lesions continue to appear in this patient, topical PDT might result in better control of HPV-induced lesions.
authors.affiliation: Department of Dermatology, University of Regensburg, D-93042 Regensburg, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Karrer
authors.forename: R M
authors.initials: RM
authors.lastname: Szeimies
authors.forename: C
authors.initials: C
authors.lastname: Abels
authors.forename: U
authors.initials: U
authors.lastname: Wlotzke
authors.forename: W
authors.initials: W
authors.lastname: Stolz
authors.forename: M
authors.initials: M
authors.lastname: Landthaler
mesh_terms: D000287:Administration, Topical; D000368:Aged; D000622:Aminolevulinic Acid / Q000008:administration & dosage*; D001132:Arm; D004279:DNA, Viral / Q000032:analysis; D004819:Epidermodysplasia Verruciformis / Q000628:therapy* / Q000821:virology; D005153:Facial Neoplasms / Q000628:therapy; D005260:Female; D005546:Forehead; D006229:Hand Dermatoses / Q000628:therapy* / Q000821:virology; D006801:Humans; D017403:In Situ Hybridization; D027383:Papillomaviridae / Q000235:genetics; D017319:Photosensitizing Agents / Q000008:administration & dosage*; D010789:Phototherapy; D012867:Skin / Q000821:virology
chemical_list: D004279:DNA, Viral; D017319:Photosensitizing Agents; D000622:Aminolevulinic Acid